Plasma levels of S100A4 in portopulmonary hypertension.
Publication/Presentation Date
5-1-2009
Abstract
We previously showed that a single nucleotide polymorphism in S100A4 was associated with portopulmonary hypertension (PPHTN) in patients with advanced liver disease. We aimed to determine the association between plasma levels of S100A4 and PPHTN. We performed a case-control study of patients with advanced liver disease. Cases with PPHTN had mean pulmonary artery pressure >25 mmHg, pulmonary vascular resistance >240 dynes s cm(-5) and pulmonary capillary wedge pressure
Volume
14
Issue
3
First Page
156
Last Page
160
ISSN
1366-5804
Published In/Presented At
Peng, T., Zamanian, R., Krowka, M. J., Benza, R. L., Roberts, K. E., Taichman, D. B., Rybak, D., Trotter, J. F., Brown, R. S., Jr, Fallon, M. B., Kawut, S. M., & Pulmonary Vascular Complications of Liver Disease Study Group (2009). Plasma levels of S100A4 in portopulmonary hypertension. Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals, 14(3), 156–160. https://doi.org/10.1080/13547500902773896
Disciplines
Medicine and Health Sciences
PubMedID
19399660
Department(s)
Fellows and Residents
Document Type
Article